Immuno therapy
Showing 9926 - 9950 of >10,000
Novel Targetable BIOmarkers in ANorexia NervosA
Recruiting
- Anorexia Nervosa
- Anorexia Nervosa Restricting Type
-
Basel, SwitzerlandUniversity Hospital Basel
May 22, 2023
Solid Tumors Trial in Shanghai City (Ipatasertib)
Active, not recruiting
- Solid Tumors
-
Shanghai City, ChinaFudan University Shanghai Cancer Center
Jan 8, 2023
Ovarian Cancer Trial in Seoul (Cellgram-DC)
Terminated
- Ovarian Cancer
- Cellgram-DC
-
Seoul, Korea, Republic ofAsan medical center
Dec 29, 2022
PD-1 Immunotherapy, VEGFR-TKI, Sarcomatoid Carcinoma Trial in Shanghai (Camrelizumab Combined With Apatinib)
Recruiting
- PD-1 Immunotherapy
- +3 more
- Camrelizumab Combined With Apatinib
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 1, 2022
Anti-hypertensive Medications on Diagnostic Accuracy in
Recruiting
- Hypertension
- Primary Aldosteronism
- withdraw antihypertensive drugs
-
Chongqing, Chongqing, China
- +1 more
Feb 17, 2022
Diabetic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)
Completed
- Diabetic Kidney Disease
- Finerenone (BAY94-8862)
- Placebo
-
Birmingham, Alabama
- +974 more
Apr 13, 2022
Gastric Cancer Trial in Tai'an (Camrelizumab Combined with SOX)
Recruiting
- Gastric Cancer
- Camrelizumab Combined with SOX
-
Tai'an, Shandong, ChinaThe Second Affiliated Hospital of Shandong First Medical Univers
Dec 22, 2021
Based on Bio-psycho-social Treatment Approach for Chronic Pelvic
Recruiting
- Pain, Chronic
- +5 more
- Learning of Coping Strategies
-
Nottwil, LU, SwitzerlandCenter of Pain Medicine
Jan 10, 2022
Circulating Tumor DNA and Immunophenotyping as Potential
Recruiting
- Breast Cancer
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 7, 2022
Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before
Not yet recruiting
- Herpes Zoster
- Recombinant Human Interferon α-2b Gel (After the Alteration)
- Recombinant Human Interferon α-2b Gel (Before the Alteration)
- (no location specified)
Apr 7, 2023
Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Statin Adverse Reaction Trial in Tunis (Atorvastatin 40 Mg Oral
Completed
- Diabetes Mellitus, Type 2
- +5 more
- Atorvastatin 40 Mg Oral Tablet
-
Tunis, TunisiaUniversity Hospital La Rabta
Apr 7, 2023
Myeloablative Allogeneic Hematopoietic Cell Transplantation, Intraoral Photobiomodulation Therapy, Oral Mucositis Trial in
Recruiting
- Myeloablative Allogeneic Hematopoietic Cell Transplantation
- +3 more
- THOR LX2.3 with LED Lollipop
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 27, 2022
Disorder Related to Lung Transplantation, CLAD, Bronchiolitis Obliterans Trial in Worldwide (Pirfenidone, Placebo)
Completed
- Disorder Related to Lung Transplantation
- CLAD, Bronchiolitis Obliterans
- Pirfenidone
- Placebo
-
Leuven, Belgium
- +8 more
Jan 16, 2020
Awake Prone Positioning, High-flow Nasal Cannula, Continuous Positive Airway Pressure Trial in Chicago (awake prone positioning
Not yet recruiting
- Awake Prone Positioning
- +2 more
- awake prone positioning with advanced respiratory support (high-flow nasal cannula or continuous positive airway pressure)
-
Chicago, IllinoisRush University Medical Center
Aug 21, 2022
ACL Tear, Arthrofibrosis, ACL Injury Trial (Lake Effect Zero Degree Knee Splint, Standard Hinge Knee Brace)
Not yet recruiting
- ACL Tear
- +2 more
- Lake Effect Zero Degree Knee Splint
- Standard Hinge Knee Brace
- (no location specified)
Jan 6, 2023
Postpartum Depression, Postpartum Disorder Trial in Madrid (Intervention in positive psychology)
Recruiting
- Postpartum Depression
- Postpartum Disorder
- Intervention in positive psychology
-
Madrid, Pozuelo De Alarcón, SpainCovadonga Chaves Vélez
Dec 21, 2022
HIV Prevention Trial in Jackson (ACTPrEP, Enhanced Standard of Care)
Not yet recruiting
- HIV Prevention
- ACTPrEP
- Enhanced Standard of Care
-
Jackson, MississippiUniveristy of Mississippi Medical Center
Apr 27, 2022
Heart Failure, Systolic Trial in Minneapolis, Saint Paul (Reprogramming of CRT Device Settings to Optimal Electrical Synchrony)
Recruiting
- Heart Failure, Systolic
- Reprogramming of CRT Device Settings to Optimal Electrical Synchrony
-
Minneapolis, Minnesota
- +1 more
Jun 8, 2022
USHer Syndrome (CRUSH) Study
Active, not recruiting
- Usher Syndrome, Type 2A
- +2 more
- No intervention
-
Nijmegen, Gelderland, NetherlandsRadboud universitair medisch centrum
Apr 28, 2022
Helicobacter Pylori Local Prevalence and Antibiotic Resistance
Recruiting
- Helicobacter Pylori Infection
- +5 more
-
Munich, GermanyDepartment of Medicine II, University Hospital of Munich
Sep 27, 2022
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +21 more
- Atezolizumab
- +8 more
-
Little Rock, Arkansas
- +97 more
Jan 27, 2023
Rheumatic Heart Disease, Cardiopulmonary Bypass, Immunotherapy Trial in Nanjing (Thymosin Alpha1, Blank Control)
Recruiting
- Rheumatic Heart Disease
- +2 more
- Thymosin Alpha1
- Blank Control
-
Nanjing, Jiangsu, ChinaThe first affiliated hospital of nanjing medical university
Aug 3, 2022
Pulmonary Function After Hyperbaric Oxygen Therapy
Active, not recruiting
- Oxygen Toxicity
- Hyperbaric Oxygen Therapy
-
Toronto, Ontario, CanadaHyperbaric Medicine Unit
May 16, 2022
Insomnia Trial in Los Angeles (Digital cognitive-behavioral therapy for insomnia (dCBTI), Sleep hygiene education (SHE))
Enrolling by invitation
- Insomnia
- Digital cognitive-behavioral therapy for insomnia (dCBTI)
- Sleep hygiene education (SHE)
-
Los Angeles, CaliforniaUCLA Cousins Center for Psychoneuroimmunology
May 17, 2022